Ketamine Infusion for Treatment-resistant Major Depressive Disorder



Status:Completed
Conditions:Depression, Major Depression Disorder (MDD)
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:9/23/2012
Start Date:April 2012
End Date:May 2014
Contact:Durham Kelley, Res. Coord.
Email:kedurham@partners.org
Phone:1-877-552-5838

Use our guide to learn which trials are right for you!

N-methyl-D-aspartate Antagonist (Ketamine) Infusion for Treatment-resistant Major Depressive Disorder With Suicidal Ideation


Ketamine infusion has been shown to have rapid antidepressant properties, however the
possible use of ketamine in treatment-resistant depression as augmentation has not been
investigated. The overall aim of this study is to assess the feasibility, safety and
tolerability, efficacy and duration of the effect of intravenous N-methyl-D-aspartate
antagonist ketamine as augmentation of antidepressants for chronic suicidal ideation in
subjects with severe treatment-resistant depression (TRD).

This is an open-label study (pilot).


Patients will undergo two weeks of prospective observation, they will then receive ketamine
IV 0.5mg/kg over 40 minutes as augmentation of their ongoing antidepressant regimen; after
three infusions this dose will be increased increase to 0.75 mg/kg in non-responders. The
schedule of administration will be twice a week for 3 weeks. After this phase, the patient
will be followed with assessments every two weeks for three months.

Total duration of the study is 4 months.

Inclusion Criteria:

- Outpatients with severe treatment-resistant MDD

- Currently depressed

- Currently under regular psychiatric care

- On an aggressive antidepressant regimen, stable for 4 weeks

Exclusion Criteria:

- No history of other major psychiatric illnesses, including bipolar disorder

- No history of psychosis

- No history of drug abuse

- No major medical illness or unstable medical conditions
We found this trial at
1
site
Boston, Massachusetts 02114
?
mi
from
Boston, MA
Click here to add this to my saved trials